Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2003
The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathwaysM J Millan, A Gobert, F Lejeune, et al.
European Journal of Pharmacology|August 1, 1994
S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in ratsM J Millan, V Audinot, J M Rivet, et al.
European Journal of Pharmacology|January 5, 1993
S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectivelyM J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626M J Millan, A Gobert, A Newman-Tancredi, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonistsM J Millan, H Canton, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Antagonist properties of LY 165,163 at pre- and postsynaptic dopamine D2, D3 and D1 receptors: modulation of agonist actions at 5-HT1A receptors in vivoM J Millan, J M Rivet, V Audinot, et al.
Synapse (New York, N.Y.)|May 20, 2000
Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the ratA Gobert, J M Rivet, F Lejeune, et al.
The European Journal of Neuroscience|April 13, 2000
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopramM J Millan, A Gobert, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidineM J Millan, F Lejeune, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsyM J Millan, J L Peglion, J Vian, et al.
Pageof 6